Terry L Bowersock

Title: Innovations of Terry L Bowersock in Vaccine Development

Introduction

Terry L Bowersock is a notable inventor based in Portage, MI (US), recognized for his contributions to vaccine technology. He holds 2 patents that focus on innovative methods for vaccinating vertebrates. His work has significant implications for improving vaccine efficacy and safety.

Latest Patents

Bowersock's latest patents include a method of vaccinating vertebrates, which provides a vaccine composition and a method of preparation. This invention involves forming a water-in-oil emulsion that includes an alginate in water, an oil, an antigen, and specific surfactants. The process includes crosslinking the alginate with various cations to create antigen-containing, crosslinked alginate microparticles. These microparticles exhibit improved antigen loading, reduced size, increased hydrophobicity, enhanced uptake by antigen sampling cells, controlled antigen release characteristics, and improved immunogenicity.

Career Highlights

Bowersock is associated with Pharmacia & Upjohn Company, where he has been instrumental in advancing vaccine research and development. His innovative approaches have contributed to the field of immunology and have the potential to enhance public health outcomes.

Collaborations

Throughout his career, Bowersock has collaborated with notable colleagues, including Paul M Guimond and Tzu-Chi R Ju, who is a woman. These collaborations have fostered a productive environment for innovation and research in vaccine technology.

Conclusion

Terry L Bowersock's work in vaccine development showcases his commitment to improving health through innovative solutions. His patents reflect a significant advancement in the field, promising better vaccination strategies for vertebrates.